Insights

Loading spinner
Gathering insights about Psioxus Therapeutics

Psioxus Therapeutics Tech Stack

Psioxus Therapeutics uses 8 technology products and services including Open Graph, Module Federation, Cart Functionality, and more. Explore Psioxus Therapeutics's tech stack below.

  • Open Graph
    Content Management System
  • Module Federation
    Development
  • Cart Functionality
    E-commerce
  • Wix eCommerce
    E-commerce
  • Sirvoy
    Hotel Management
  • Google Cloud
    Infrastructure As A Service
  • Priority Hints
    Performance
  • Google Analytics
    Web Analytics

Media & News

Psioxus Therapeutics's Email Address Formats

Psioxus Therapeutics uses at least 2 format(s):
Psioxus Therapeutics Email FormatsExamplePercentage
First.Last@psioxus.comJohn.Doe@psioxus.com
85%
FiLast@psioxus.comJoDoe@psioxus.com
4%
LastFir@psioxus.comDoeJoh@psioxus.com
4%
Last@psioxus.comDoe@psioxus.com
2%
First.Middle@psioxus.comJohn.Michael@psioxus.com
1%
Last.First@psioxus.comDoe.John@psioxus.com
1%
FMiddleLast@psioxus.comJMichaelDoe@psioxus.com
1%
FirLast@psioxus.comJohDoe@psioxus.com
1%
F-Last@psioxus.comJ-Doe@psioxus.com
1%

Frequently Asked Questions

Where is Psioxus Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Psioxus Therapeutics's main headquarters is located at 245 Main Street 2nd Floor Cambridge, Massachusetts United States. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Psioxus Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Psioxus Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Psioxus Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Psioxus Therapeutics's official website is akamisbio.com and has social profiles on LinkedInCrunchbase.

What is Psioxus Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Psioxus Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Psioxus Therapeutics have currently?

Minus sign iconPlus sign icon
As of March 2026, Psioxus Therapeutics has approximately 35 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Vp Finance And Business Management: N. S.Vice President Immunology: P. C.Head Of Business Development & Alliance Management: S. R.. Explore Psioxus Therapeutics's employee directory with LeadIQ.

What industry does Psioxus Therapeutics belong to?

Minus sign iconPlus sign icon
Psioxus Therapeutics operates in the Biotechnology Research industry.

What technology does Psioxus Therapeutics use?

Minus sign iconPlus sign icon
Psioxus Therapeutics's tech stack includes Open GraphModule FederationCart FunctionalityWix eCommerceSirvoyGoogle CloudPriority HintsGoogle Analytics.

What is Psioxus Therapeutics's email format?

Minus sign iconPlus sign icon
Psioxus Therapeutics's email format typically follows the pattern of First.Last@psioxus.com. Find more Psioxus Therapeutics email formats with LeadIQ.

How much funding has Psioxus Therapeutics raised to date?

Minus sign iconPlus sign icon
As of March 2026, Psioxus Therapeutics has raised $60M in funding. The last funding round occurred on Dec 17, 2024 for $60M.

When was Psioxus Therapeutics founded?

Minus sign iconPlus sign icon
Psioxus Therapeutics was founded in 2010.

Psioxus Therapeutics

Biotechnology ResearchMassachusetts, United States11-50 Employees

Headquartered in Cambridge, Massachusetts, Akamis Bio is a clinical-stage oncology company developing systemically administered immunotherapies to treat solid tumors, initially in patients with locally advanced rectal cancer (LARC). Its proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform is designed to deliver novel immunotherapeutic proteins, biomolecules and transgene combinations to treat solid tumors, with its lead clinical-stage program, NG-350A, driving intratumoral expression of a CD40 agonist monoclonal antibody. To learn more, please visit www.akamisbio.com

Section iconCompany Overview

Headquarters
245 Main Street 2nd Floor Cambridge, Massachusetts United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
11-50

Section iconFunding & Financials

  • $60M

    Psioxus Therapeutics has raised a total of $60M of funding over 10 rounds. Their latest funding round was raised on Dec 17, 2024 in the amount of $60M.

  • $10M$25M

    Psioxus Therapeutics's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $60M

    Psioxus Therapeutics has raised a total of $60M of funding over 10 rounds. Their latest funding round was raised on Dec 17, 2024 in the amount of $60M.

  • $10M$25M

    Psioxus Therapeutics's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.